BR9908823A - Compostos e processos para terapia e diagnóstico de câncer de pulmão - Google Patents

Compostos e processos para terapia e diagnóstico de câncer de pulmão

Info

Publication number
BR9908823A
BR9908823A BR9908823-1A BR9908823A BR9908823A BR 9908823 A BR9908823 A BR 9908823A BR 9908823 A BR9908823 A BR 9908823A BR 9908823 A BR9908823 A BR 9908823A
Authority
BR
Brazil
Prior art keywords
lung cancer
processes
cancer therapy
polypeptides
compounds
Prior art date
Application number
BR9908823-1A
Other languages
English (en)
Inventor
Steven G Reed
Tongtong Wang
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/040,984 external-priority patent/US6210883B1/en
Priority claimed from US09/123,912 external-priority patent/US6312695B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of BR9908823A publication Critical patent/BR9908823A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSTOS E PROCESSOS PARA TERAPIA E DIAGNóSTICO DE CâNCER DE PULMãO" São providos compostos e processos para tratamento e diagnóstico de câncer de pulmão. Os compostos da invenção incluem polipeptídeos contendo pelo menos uma porção de uma proteína de tumor de pulmão. São também providas vacinas e composições farmacêuticas para imunoterapia de câncer de pulmão compreendendo tais polipeptídeos ou moléculas de DNA codificando tais polipeptídeos, juntamente com moléculas de DNA para preparação dos polipeptídeos da invenção.
BR9908823-1A 1998-03-18 1999-03-17 Compostos e processos para terapia e diagnóstico de câncer de pulmão BR9908823A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4080298A 1998-03-18 1998-03-18
US09/040,984 US6210883B1 (en) 1998-03-18 1998-03-18 Compounds and methods for diagnosis of lung cancer
US12393398A 1998-07-27 1998-07-27
US09/123,912 US6312695B1 (en) 1998-03-18 1998-07-27 Compounds and methods for therapy of lung cancer
PCT/US1999/005798 WO1999047674A2 (en) 1998-03-18 1999-03-17 Compounds and methods for therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
BR9908823A true BR9908823A (pt) 2000-11-21

Family

ID=27488687

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908823-1A BR9908823A (pt) 1998-03-18 1999-03-17 Compostos e processos para terapia e diagnóstico de câncer de pulmão

Country Status (13)

Country Link
EP (1) EP1064372B1 (pt)
JP (1) JP2002533056A (pt)
CN (1) CN1299414A (pt)
AT (1) ATE345387T1 (pt)
AU (1) AU3094999A (pt)
BR (1) BR9908823A (pt)
CA (1) CA2323093A1 (pt)
DE (1) DE69933998T2 (pt)
ES (1) ES2277432T3 (pt)
IL (1) IL138330A0 (pt)
NO (1) NO20004631L (pt)
NZ (1) NZ506699A (pt)
WO (1) WO1999047674A2 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US7338937B2 (en) * 1997-11-17 2008-03-04 Cornell Research Foundation, Inc. Calcium-activated chloride channel proteins and their use in anti-metastatic therapy
WO1999040183A1 (en) 1998-02-06 1999-08-12 Human Genome Sciences, Inc. Human serine protease and serpin polypeptides
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20040235072A1 (en) * 1998-03-18 2004-11-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
ATE366810T1 (de) 1998-03-27 2007-08-15 Otsuka Pharma Co Ltd Menschliche p51-gene und deren genprodukte
DE19822985C1 (de) * 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie
US6528054B1 (en) * 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6335170B1 (en) 1999-02-22 2002-01-01 Torben F. Orntoft Gene expression in bladder tumors
ATE399793T1 (de) * 1999-04-02 2008-07-15 Corixa Corp Verbindungen und verfahren für therapie und diagnose von lungenkrebs
DE19924199A1 (de) * 1999-05-27 2000-11-30 Boehringer Ingelheim Int Tumorassoziiertes Antigen
CA2383358A1 (en) * 1999-08-31 2001-03-08 Board Of Regents, The University Of Texas System Methods and compositions of a novel serine protease inhibitor
US6855806B1 (en) 1999-10-15 2005-02-15 Curagen Corporation Thymosin beta 10-like proteins and nucleic acids encoding same
EP1222272A2 (en) * 1999-10-15 2002-07-17 Curagen Corporation Polypeptides and polynucleotides encoding same
US6992170B2 (en) 1999-10-15 2006-01-31 Curagen Corporation Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin
KR20020064901A (ko) * 1999-11-24 2002-08-10 다케다 야쿠힌 고교 가부시키가이샤 질환관련 유전자의 용도
US20020009758A1 (en) * 2000-05-26 2002-01-24 Harlocker Susan L. Compositions and methods for the therapy and diagnosis of lung cancer
AU2001266790A1 (en) * 2000-06-09 2001-12-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
EP1356093A2 (en) * 2000-06-21 2003-10-29 Hitachi Chemical Co., Ltd. Gene markers for lung cancer
EP1319069B1 (en) * 2000-06-28 2008-05-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
JP2004524003A (ja) * 2000-06-29 2004-08-12 コリクサ コーポレイション 肺癌の治療および診断のための組成物および方法
US7141365B2 (en) 2001-05-18 2006-11-28 Syntex (U.S.A.) Llc Methods for diagnosing a mucin production associated disease condition
EP1428882A4 (en) 2001-08-24 2005-05-25 Hisamitsu Pharmaceutical Co DIFFERENT EXPRESSION IN HEPATOBLASTOM AND NORMAL LIVER DISPLAYING NUCLEIC ACIDS
ATE518884T1 (de) 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
MX2011013385A (es) * 2009-06-11 2012-05-29 Minerva Biotechnologies Corp Metodos para cultivar celulas madre y celulas progenitoras.
MX361929B (es) 2010-11-19 2018-12-19 Eisai R&D Man Co Ltd Star Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.
CN117417938A (zh) * 2022-01-31 2024-01-19 奥明(杭州)生物医药有限公司 一种环状rna分子及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
WO1999047674A2 (en) 1999-09-23
NO20004631L (no) 2000-11-15
CA2323093A1 (en) 1999-09-23
DE69933998T2 (de) 2007-10-04
ES2277432T3 (es) 2007-07-01
AU3094999A (en) 1999-10-11
JP2002533056A (ja) 2002-10-08
NZ506699A (en) 2003-12-19
EP1064372A2 (en) 2001-01-03
IL138330A0 (en) 2001-10-31
NO20004631D0 (no) 2000-09-15
EP1064372B1 (en) 2006-11-15
ATE345387T1 (de) 2006-12-15
DE69933998D1 (de) 2006-12-28
WO1999047674A3 (en) 2000-01-20
CN1299414A (zh) 2001-06-13

Similar Documents

Publication Publication Date Title
NO20004631L (no) Forbindelser og fremgangsmÕter for terapi og diagnose av lungekreft
PL354348A1 (en) Compounds and methods for therapy and diagnosis of lung cancer
TW581808B (en) Compounds for immunotherapy of prostate cancer and methods for their use
WO1999038973A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
WO1999033869A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1998037093A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
HUP0203035A2 (hu) Prosztatarák terápiájára és diagnózisára alkalmas vegyületek és eljárások
AR006250A1 (es) Compuestos y metodos para la inmunoterapia e inmunodiagnostico del cancer prostatico
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO1996040039A3 (en) Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
WO1998045328A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
ATE514780T1 (de) Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
IL207012A0 (en) Diagnosis and therapy of cancer using sgp28-related molecules
WO1999037775A3 (en) Compositions and methods for detecting and treating breast cancer
UY26170A1 (es) Antigeno (c42) asociados a tumores
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
WO2004015390A3 (en) Lung cancer target proteins and use thereof
EP2003201A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
CO5050254A1 (es) Compuestos para el tratamiento y diagnostico del cancer de pulmon
WO2003042700A3 (en) Breast cancer associated polypeptide
WO1999054466A3 (en) Colon cancer-associated antigens and their diagnostic and therapeutic uses

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]